Articles > Popular publications > PR Newswire press releases > January-March 2008 > Tuesday, February 12

Article: Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future.

Article from:
PR Newswire
Article date:
February 12, 2008
Copyright

BETHESDA, Md., Feb. 12 /PRNewswire-FirstCall/ -- Micromet, Inc. , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the publication of a comprehensive review article entitled, "BiTE: A new class of antibodies that recruit T cells" in the journal Drugs of the Future. BiTE(R) antibodies are designed to activate the body's T cells to seek and destroy cancer cells in a tightly controlled manner.

The review article discusses recently published preclinical and clinical data on BiTE antibodies, which are evolving into a new class of antibody-based therapeutics, with ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Micromet Presents Safety and Efficacy Data from Primate ...
PR Newswire;  April 14, 2008 ;     700+ words ... ... Several antibodies in Micromet's product pipeline are BiTE antibodies and have been generated based on Micromet's proprietary ... Two additional BiTE antibodies, targeting CEA ... development. About Micromet, Inc. (http ...

Article: Micromet Demonstrates That the Antibodies in Commercial ...
PR Newswire;  April 14, 2008 ;     700+ words ... ... other diseases. All four BiTE antibodies were constructed using Micromet's novel proprietary ... Several antibodies in Micromet's product pipeline are BiTE antibodies and have been generated based on Micromet's proprietary BiTE ...

Article: Micromet Presents Preclinical Data Showing Activity of ...
PR Newswire;  April 22, 2009 ;     700+ words ... ... clinical data indicate that after Micromet developed BiTE antibodies from the EGFR-specific monoclonal ... bispecific antibodies based on Micromet's proprietary BiTE technology. Both of Micromet's EGFR BiTE antibodies were able to direct T cells ...

Article: Micromet to Present Six Posters on Progress of BiTE ...
PR Newswire;  March 16, 2009 ;     700+ words ... ... PRNewswire-FirstCall/ -- Micromet, Inc. , a biopharmaceutical ... by T cell-engaging BiTE antibodies derived from anti ... metastatic breast cancer. Micromet licensed a fourth clinical ... multiple sclerosis. Micromet has granted an exclusive ... target. Additional BiTE antibodies, ...

Article: Micromet's BiTE(R) Antibodies Reveal Unique Mode of ...
PR Newswire;  November 6, 2007 ;     700+ words ... ... Patrick Baeuerle, Micromet's Chief Scientific ... activating agents, BiTE antibodies activate T cells ... Several antibodies in Micromet's product pipeline are BiTE antibodies and have been generated based on Micromet's proprietary ...

Article: Micromet Enters Into Agreement for Solid Tumor BiTE ...
PR Newswire;  January 12, 2009 ;     700+ words ... ... license to one of Micromet's preclinical BiTE antibodies against an undisclosed ... Pharma will pay Micromet a Euro 4.5 million ... are excited about Micromet's BiTE antibody technology and believe BiTE antibodies represent a novel ...

Article: Micromet Enrolls First Patient in a Phase 1 Clinical Trial ...
PR Newswire;  April 23, 2008 ;     700+ words ... ... Several antibodies in Micromet's product pipeline are BiTE antibodies and have been generated based on Micromet's proprietary ... Two additional BiTE antibodies, targeting CD33 ... development. About Micromet, Inc. (http ...

Article: Micromet, Inc. Reports First Quarter 2008 Financial ...
PR Newswire;  May 8, 2008 ;     700+ words ... ... Also in April, Micromet presented five ... platform and new BiTE antibodies: -- Commercial ... Executive Officer of Micromet said: "We have ... potential utility of BiTE antibodies for the treatment ... highly potent BiTE antibodies with differentiated ... March 31, 2008, ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives